Legend Biotech (LEGN) Earnings: What to Watch When Carvykti Reports
As seen on the 24/7 Wall St. homepage on August 11, 2026.
Legend Biotech reports at 7:00 AM ET, and the only question that matters is whether Carvykti's growth is still outpacing J&J's Tecvayli with anito-cel's launch closing in. Manufacturing capacity commentary moves this $4 billion stock as much as the numbers do.
Continue ReadingShow less
Legend Biotech is set to release its results before the market opens on August 11, 2026, with the report confirmed for 7:00 AM ET. The central question heading into the print is whether Carvykti's growth trajectory is still running ahead of Johnson & Johnson's Tecvayli, a rivalry that has become a defining benchmark for how the market values Legend's commercial execution.
Equally important to watch is what management says about manufacturing capacity. Commentary on that front has historically moved this roughly $4 billion stock as meaningfully as the headline revenue and earnings figures themselves, reflecting investor sensitivity to any constraint that could slow Carvykti's rollout.
Adding urgency to this particular report is the approaching launch of anito-cel, a competing therapy whose entry into the market could pressure both Carvykti's growth rate and Legend's pricing power going forward. Investors will be listening closely for any guidance that addresses how the company plans to defend its position as that competitive landscape shifts.
Sources
Mentioned: LEGN
Disclosure
*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term. Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.